In October 2023, Tevogen Bio launched its artificial intelligence effort, Tevogen.AI with the explicit goal to expedite enhancement of drug discovery, development, manufacturing, distribution, and ...
(RTTNews) - GRI Bio Inc. (GRI) has announced positive topline data from its Phase 2a study evaluating GRI-0621 in patients with Idiopathic Pulmonary Fibrosis. Idiopathic Pulmonary Fibrosis (IPF) is a ...
Bio-Techne is a market leader in proteins for the pharma, biotech, academic, and diagnostic markets and maintains strong market positioning in antibodies and testing controls for diagnostic partners.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback